Scandinavian Real Heart AB (Publ) (HEART.ST)

SEK 12.54

(-2.79%)

Revenue Summary of Scandinavian Real Heart AB (Publ)

  • Scandinavian Real Heart AB (Publ)'s latest annual revenue in 2023 was - SEK , down -100.0% from previous year.
  • Scandinavian Real Heart AB (Publ)'s latest quarterly revenue in 2024 Q1 was - SEK , down 0.0% from previous quarter.
  • Scandinavian Real Heart AB (Publ) reported a annual revenue of 10 Thousand SEK in annual revenue 2022, down 0.0% from previous year.
  • Scandinavian Real Heart AB (Publ) reported a annual revenue of - SEK in annual revenue 2021, down 0.0% from previous year.
  • Scandinavian Real Heart AB (Publ) reported a quarterly revenue of - SEK for 2024 Q1, down 0.0% from previous quarter.
  • Scandinavian Real Heart AB (Publ) reported a quarterly revenue of - SEK for 2023 FY, down -100.0% from previous quarter.

Annual Revenue Chart of Scandinavian Real Heart AB (Publ) (2023 - 2010)

Historical Annual Revenue of Scandinavian Real Heart AB (Publ) (2023 - 2010)

Year Revenue Revenue Growth
2023 - SEK -100.0%
2022 10 Thousand SEK 0.0%
2021 - SEK 0.0%
2020 - SEK 0.0%
2019 - SEK -100.0%
2018 111.34 Thousand SEK -85.63%
2017 774.96 Thousand SEK 484.11%
2016 132.67 Thousand SEK -10.39%
2015 148.05 Thousand SEK -34.56%
2014 226.25 Thousand SEK 50973.81%
2013 443.00 SEK 0.0%
2012 - SEK -100.0%
2011 1.00 SEK -91.67%
2010 12.00 SEK 0.0%

Peer Revenue Comparison of Scandinavian Real Heart AB (Publ)

Name Revenue Revenue Difference
Acarix AB (publ) 6.24 Million SEK 100.0%
ADDvise Group AB (publ) 1.37 Billion SEK 100.0%
ADDvise Group AB (publ) 1.37 Billion SEK 100.0%
Arcoma AB 163.01 Million SEK 100.0%
Bactiguard Holding AB (publ) 203.99 Million SEK 100.0%
BICO Group AB (publ) 2.23 Billion SEK 100.0%
Boule Diagnostics AB (publ) 571.32 Million SEK 100.0%
CellaVision AB (publ) 677.29 Million SEK 100.0%
Clinical Laserthermia Systems AB (publ) 8.27 Million SEK 100.0%
Chordate Medical Holding AB (publ) 976.28 Thousand SEK 100.0%
C-Rad AB (publ) 424.61 Million SEK 100.0%
Duearity AB (publ) 1.65 Million SEK 100.0%
Dignitana AB (publ) 86.06 Million SEK 100.0%
Episurf Medical AB (publ) 10.3 Million SEK 100.0%
Getinge AB (publ) 31.82 Billion SEK 100.0%
Iconovo AB (publ) 7.07 Million SEK 100.0%
Integrum AB (publ) 104.11 Million SEK 100.0%
Luxbright AB (publ) 854.69 Thousand SEK 100.0%
Mentice AB (publ) 273.61 Million SEK 100.0%
OssDsign AB (publ) 112.15 Million SEK 100.0%
Paxman AB (publ) 210.11 Million SEK 100.0%
Promimic AB (publ) 37.07 Million SEK 100.0%
Qlife Holding AB (publ) 244 Thousand SEK 100.0%
SciBase Holding AB (publ) 23.24 Million SEK 100.0%
ScandiDos AB (publ) 60.42 Million SEK 100.0%
Sectra AB (publ) 2.96 Billion SEK 100.0%
Sedana Medical AB (publ) 153.86 Million SEK 100.0%
Senzime AB (publ) 35.75 Million SEK 100.0%
SpectraCure AB (publ) 318 Thousand SEK 100.0%
Stille AB 294.89 Million SEK 100.0%
Vitrolife AB (publ) 3.51 Billion SEK 100.0%
Xvivo Perfusion AB (publ) 597.54 Million SEK 100.0%